相关实验视频

Updated: Jul 10, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

埃弗罗利斯对调节宿主免疫反应对Mycobacterium tuberculosis感染的作用

Anmol Raien¹, Sofia Davis¹, Michelle Zhang¹

¹College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.

|November 24, 2023

概括

埃弗罗利斯作为结核病 (TB) 的辅助疗法显示出前景. 这种mTOR抑制剂降低了结核病患者的糖溶性活性和改善了肺功能 (FEV1),这表明它可以减轻炎症和肺损伤.

科学领域:

免疫学免疫学免疫学
药理学药理学是指药理学的学科.
传染性疾病传染性疾病

背景情况:

拉巴胺素 (PI3K/AKT/mTOR) 途径的氨酸-3-酶/蛋白酶B/哺乳动物标被认为是结核病 (TB) 的致病因子.
调节这种途径为宿主导结核病疗法提供了潜力,尽管其在活跃感染中的作用仍在争论中.
有关潜在宿主组织破坏和感染途径抑制剂增加感染风险存在担忧.

研究的目的:

为了研究everolimus的潜力,一个mTOR抑制剂,作为结核病的辅助疗法.
评估Everolimus对结核病患者代谢转变和肺功能的影响.

主要方法:

进行了一项临床试验,重点是接受everolimus作为辅助结核病治疗的患者.
测量了新陈代谢活动,特别是糖解.
用1秒 (FEV1) 测量强迫呼气体积来评估肺功能.

主要成果:

与对照组相比,Everolimus组表现出最大和峰值糖解活性减少的程度更大.
用everolimus治疗的患者表现出改善的肺功能,由更高的FEV1测量结果表明.
这些发现表明,everolimus可能有助于减轻结核病中与炎症相关的肺损伤.

结论:

埃弗罗利斯显示出作为结核病辅助治疗的潜力.
该药物可以抵消结核病感染中出现的代谢转向糖解的转变.
在结核病患者中,Everolimus可能在减少炎症和保持肺功能方面发挥作用.

关键词:

结核病菌菌菌的结核病菌的结核病菌.自自是自的过程.这是Everolimus.主体导向疗法主体导向疗法在mTOROR中使用mTOR.

更多相关视频

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

相关概念视频

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Defense Against Bacterial Pathogens

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...